Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017, Article ID 7019803, 12 pages
https://doi.org/10.1155/2017/7019803
Research Article

Nicotinamide Administration Improves Remyelination after Stroke

Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, China

Correspondence should be addressed to Gao-Jun Teng; moc.anis.piv@gnetjg

Received 15 December 2016; Revised 16 February 2017; Accepted 13 March 2017; Published 1 June 2017

Academic Editor: Long-Jun Wu

Copyright © 2017 Congxiao Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. Lo, T. Dalkara, and M. A. Moskowitz, “Mechanisms, challenges and opportunities in stroke,” Nature Reviews Neuroscience, vol. 4, no. 5, pp. 399–415, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, “Tissue plasminogen activator for acute ischemic stroke,” The New England Journal of Medicine, vol. 333, no. 24, pp. 1581–1588, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Hacke, M. Kaste, E. Bluhmki et al., “Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke,” New England Journal of Medicine, vol. 359, no. 13, pp. 1317–1329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. R. Lees, E. Bluhmki, R. Von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Gumbinger, B. Reuter, C. Stock et al., “Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials,” BMJ, vol. 348, p. g3429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Hacke, G. Donnan, C. Fieschi et al., “Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials,” The Lancet, vol. 363, no. 9411, pp. 768–774, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Eckert, Q. Vu, K. Xie et al., “Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 9, pp. 1322–1334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. G. Sozmen, J. D. Hinman, and S. T. Carmichael, “Models that matter: white matter stroke models,” Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, vol. 9, no. 2, pp. 349–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. P. Goldberg and B. R. Ransom, “New light on white matter,” Stroke, vol. 34, no. 2, pp. 330–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Matute, M. Domercq, A. Perez-Samartin, and B. R. Ransom, “Protecting white matter from stroke injury,” Stroke, vol. 44, no. 4, pp. 1204–1211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Hamner, T. Moller, and B. R. Ransom, “Anaerobic function of CNS white matter declines with age,” Journal of Cerebral Blood Flow & Metabolism, vol. 31, no. 4, pp. 996–1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Saab and K.-A. Nave, “Neuroscience: a mechanism for myelin injury,” Nature, vol. 529, no. 7587, pp. 474-475, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. K. A. Nave, “Myelination and support of axonal integrity by glia,” Nature, vol. 468, no. 7321, pp. 244–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. K. Bercury and W. B. Macklin, “Dynamics and mechanisms of CNS myelination,” Developmental Cell, vol. 32, no. 4, pp. 447–458, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. N. B. Hamilton, K. Kolodziejczyk, E. Kougioumtzidou, and D. Attwell, “Proton-gated Ca2+−permeable TRP channels damage myelin in conditions mimicking ischaemia,” Nature, vol. 529, no. 7587, pp. 523–527, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Sauve, “NAD+ and vitamin B3: from metabolism to therapies,” The Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 3, pp. 883–893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Rennie, A. C. Chen, H. Dhillon, J. Vardy, and D. L. Damian, “Nicotinamide and neurocognitive function,” Nutritional Neuroscience, vol. 18, no. 5, pp. 193–200, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Hathorn, A. Snyder-Keller, and A. Messer, “Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington’s disease,” Neurobiology of Disease, vol. 41, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Maiese and Z. Z. Chong, “Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain,” Trends in Pharmacological Sciences, vol. 24, no. 5, pp. 228–232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Chen, A. J. Martin, B. Choy et al., “A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention,” The New England Journal of Medicine, vol. 373, no. 17, pp. 1618–1626, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. E. A. M. Gale, “European nicotinamide diabetes intervention trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes,” The Lancet, vol. 363, no. 9413, pp. 925–931, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Libri, C. Yandim, S. Athanasopoulos et al., “Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich’s ataxia: an exploratory, open-label, dose-escalation study,” The Lancet, vol. 384, no. 9942, pp. 504–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Y. Bai, L. Wang, D. Chang et al., “Synergistic effects of transplanted endothelial progenitor cells and RWJ 67657 in diabetic ischemic stroke models,” Stroke, vol. 46, no. 7, pp. 1938–1946, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Saiki, K. Nishimura, I. Ishii et al., “Intense correlation between brain infarction and protein-conjugated acrolein,” Stroke, vol. 40, no. 10, pp. 3356–3361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Cui, M. Chopp, A. Zacharek, Y. Cui, C. Roberts, and J. Chen, “The neurorestorative benefit of GW3965 treatment of stroke in mice,” Stroke, vol. 44, no. 1, pp. 153–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Chen, P. R. Sanberg, Y. Li et al., “Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats,” Stroke, vol. 32, no. 11, pp. 2682–2688, 2001. View at Publisher · View at Google Scholar
  27. I. A. Ayoub, E. J. Lee, C. S. Ogilvy, M. F. Beal, and K. I. Maynard, “Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats,” Neuroscience Letters, vol. 259, no. 1, pp. 21–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Mokudai, I. A. Ayoub, Y. Sakakibara, E.-J. Lee, C. S. Ogilvy, and K. I. Maynard, “Delayed treatment with nicotinamide (vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats,” Stroke, vol. 31, no. 7, pp. 1679–1685, 2000. View at Publisher · View at Google Scholar
  29. G. Ding, J. Chen, M. Chopp et al., “White matter changes after stroke in type 2 diabetic rats measured by diffusion magnetic resonance imaging,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 1, p. 241, 2017. View at Publisher · View at Google Scholar
  30. S. Van Cauter, J. Veraart, J. Sijbers et al., “Gliomas: diffusion kurtosis MR imaging in grading,” Radiology, vol. 263, no. 2, pp. 492–501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. P. C. Li, Y. Jiao, J. Ding et al., “Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice,” CNS Neuroscience & Therapeutics, vol. 21, no. 3, pp. 231–240, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Y. Bai, X. Gao, Y. C. Wang et al., “Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe,” Theranostics, vol. 4, no. 8, pp. 787–797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Fargali, M. Sadahiro, C. Jiang et al., “Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis,” Journal of Molecular Neuroscience: MN, vol. 48, no. 3, pp. 654–659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. V. Chao, “Neurotrophins and their receptors: a convergence point for many signalling pathways,” Nature Reviews Neuroscience, vol. 4, no. 4, pp. 299–309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. E. J. Huang and L. F. Reichardt, “Neurotrophins: roles in neuronal development and function,” Annual Review of Neuroscience, vol. 24, no. 1, pp. 677–736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Xiao, A. W. Wong, M. M. Willingham, M. van den Buuse, T. J. Kilpatrick, and S. S. Murray, “Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes,” Neuro-Signals, vol. 18, no. 3, pp. 186–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. W. Vondran, P. Clinton-Luke, J. Z. Honeywell, and C. F. Dreyfus, “BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain,” Glia, vol. 58, no. 7, pp. 848–856, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Cellerino, P. Carroll, H. Thoenen, and Y.-A. Barde, “Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor,” Molecular and Cellular Neuroscience, vol. 9, no. 5, pp. 397–408, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Son, M. Y. Son, B. Seol et al., “Nicotinamide overcomes pluripotency deficits and reprogramming barriers,” Stem Cells, vol. 31, no. 6, pp. 1121–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Verdin, “NAD+ in aging, metabolism, and neurodegeneration,” Science, vol. 350, no. 6265, pp. 1208–1213, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Chang, B. Zhang, H. Heath, N. Galjart, X. Wang, and J. Milbrandt, “Nicotinamide adenine dinucleotide (NAD)–regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus,” Proceedings of the National Academy of Sciences, vol. 107, no. 50, pp. 21836–21841, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Liu, R. Gharavi, M. Pitta, M. Gleichmann, and M. P. Mattson, “Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons,” Neuromolecular Medicine, vol. 11, no. 1, pp. 28–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Sadanaga-Akiyoshi, H. Yao, S. I. Tanuma et al., “Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra,” Neurochemical Research, vol. 28, no. 8, pp. 1227–1234, 2003. View at Publisher · View at Google Scholar · View at Scopus